Skip to main content

Market Overview

Why Nemaura Medical's Stock Surged 135% Today

Why Nemaura Medical's Stock Surged 135% Today

Nemaura Medical Inc. (NASDAQ: NMRD) shares are trading higher after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.

The company also announced there is an additional rolling monthly purchase order forecast for the next 24 months of 15,000 transmitters and 2.1 million sensors, with an option to increase volumes based on customer response.

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices.

Nemaura Medical's stock closed up 135% at $11.06. The stock has a 52-week high of $16.50 and a 52-week low of $3.12.


Related Articles (NMRD)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Contracts Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at